Comment on "Aberrant type 1 immunity drives susceptibility to mucosal fungal infections"
- PMID: 34529474
- DOI: 10.1126/science.abi6235
Comment on "Aberrant type 1 immunity drives susceptibility to mucosal fungal infections"
Abstract
Break et al. (Research Articles, 15 January 2021, eaay5731) conclude that T cell overproduction of interferon-γ causes chronic mucocutaneous candidiasis (CMC), a typical early feature of autoimmune polyendocrinopathy–candidiasis–ectodermal dystrophy (APECED). This contradicts studies implicating interleukin IL-17 and IL-22 deficiencies as a cause of CMC. We propose that Break et al. have focused on late-arising events rather than more common primary causes of CMC.
Comment in
-
Response to Comments on "Aberrant type 1 immunity drives susceptibility to mucosal fungal infections".Science. 2021 Sep 17;373(6561):eabi8835. doi: 10.1126/science.abi8835. Epub 2021 Sep 16. Science. 2021. PMID: 34529475 Free PMC article.
Comment on
-
Aberrant type 1 immunity drives susceptibility to mucosal fungal infections.Science. 2021 Jan 15;371(6526):eaay5731. doi: 10.1126/science.aay5731. Science. 2021. PMID: 33446526 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
